Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

DASH PHARMS

  • FDA Approval
  • Aug. 25, 2025, 09:01 UTC
  • 58
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Aug. 25, 2025, 09:01 UTC
  • 54
  • 0 comments

FDA approve TOPIRAMATE

Comment Full text

DASH PHARMS

  • FDA Approval
  • Aug. 25, 2025, 09:01 UTC
  • 52
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

ZHEJIANG NUODE

  • FDA Approval
  • Aug. 25, 2025, 09:01 UTC
  • 59
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

IONIS PHARMS INC

  • FDA Approval
  • Aug. 22, 2025, 17:09 UTC
  • 95
  • 0 comments

FDA approve DONIDALORSEN INJECTION

Comment Full text

PFIZER INC

  • FDA Approval
  • Aug. 22, 2025, 16:55 UTC
  • 83
  • 0 comments

FDA approve TRASTUZUMAB-QYYP

Comment Full text

NANJING KING-FRIEND

  • FDA Approval
  • Aug. 22, 2025, 09:34 UTC
  • 78
  • 0 comments

FDA approve NICARDIPINE HYDROCHLORIDE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • Aug. 22, 2025, 09:34 UTC
  • 68
  • 0 comments

FDA approve SCOPOLAMINE

Comment Full text

MSN

  • FDA Approval
  • Aug. 22, 2025, 09:34 UTC
  • 71
  • 0 comments

FDA approve MACITENTAN

Comment Full text

ABBVIE

  • FDA Approval
  • Aug. 22, 2025, 09:34 UTC
  • 74
  • 0 comments

FDA approve CYCLOSPORINE

Comment Full text
  • Previous
  • 97
  • 98
  • 99
  • 100
  • 101
  • Next

Search

News categories

  • Technical Exchange News(12220)
  • Event(6113)
  • SEC News(262591)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(153949)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin